- We are Kardia Farma Solusindo
New Mind of Future
Oncology Precision Medicine
Provides early diagnosis for accurate treatment to improve patient outcome.
Why KFS
Become a Pioneer in the development & production of innovative radiopharmaceuticals
Choosing a radiopharmacy supplier is a critical decision for medical facilities, especially those involved in nuclear medicine and molecular imaging.
Unmatched Production Capacity
Largest production capacity in indonesia, the first to use the Kiube 300 for unmatched production capacity.
Strategic Location Advantage
Strategic location, close to the highways and airport. Makes it more efficient in transporting radio pharmacy. The Half-life Matter!
Expert Team forExcellence
Team of Expert in radiopharmacy production to ensure quality, consistency, safety, reliable and responsive customer support.
Facilities
Innovative Products
Kardia Farma Solusindo Comitted on delivering quality radiopharmaceutical products with the best value
Everything is designed to ensure production with great quality.
Cylotron IBA Kiuebe 300
The IBA Cyclone® KIUBE 300 sets a new standard for PET cyclotron production capacity, achieving an unparalleled output of up to 300 FDG* doses within just two hours. This remarkable capability makes it one of the most efficient and powerful tools available for radiopharmaceutical production.
PET Tracer Synthesizer
A machine that produces molecular imaging tracers for Positron Emission Tomography (PET) scans
Our Product
F-18 Choline
F18-choline (FCH) PET/CT for parathyroid adenoma detection prior to surgery
F-18 FET
18F-fluoro-ethyl-tyrosine (18F-FET) has been used in the evaluation of patients
F-18 MISO
F18 Fluoromisonidazole for Imaging Tumor Hypoxia: Imaging the Microenvironment for
F-18 Cardiac Perfusion
Myocardial perfusion imaging (MPI) with single photon emission computed tomography
F-18 Prostate-specific membrane antigen (PSMA)
Prostate-specific membrane antigen (PSMA)-targeted PET imaging has changed the management
[18F] Fluorodeoxyglucose (FDG)
Fludeoxyglucose (18F) 185 MBq/mL solution for injection. FDG is a
[18F] Fibroblast-Activation Protein Inhibitor (FAPI)
Fibroblast Activation Protein Inhibitor (FAPI) therapy, is a relatively new and
[18F] Fluorothymidine (FLT)
A radioactive substance being studied in the diagnosis of cancer.
[18F] Fluorodopa (F-DOPA)
Fluorodopa is indicated for use in positron emission tomography (PET)
Recent News
Healthcare stocks fall as lawmakers push for bill to break up drug middlemen
A general view shows a sign of CVS Health Retail
MeDevIS platform announced to boost access to medical technologies and devices
World Health Organization (WHO) has introduced an online platform called MeDevIS (Medical
New Radiopharmacy Database: Enhancing Development, Collaboration and Research
A new IAEA radiopharmacy database will facilitate research, collaboration and